Metrics and reporting
At Novartis, we are committed to transparent reporting – a central part of our UN Global Compact obligations. In addition to our Annual Report, which serves as our primary reporting mechanism, we also publish:
Local websites
General contact
Head Office
Novartis International AG
CH-4002 Basel
Switzerland
+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)
Investors
Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland
+41 61 324 79 44
investor.relations@novartis.com
Media
Global Media Relations
Eric Althoff
Basel, Switzerland
+41 61 324 7999
eric.althoff@novartis.com
Reporting side effects
Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.
pane 4 content
Novartis country websites:
Novartis business websites:
Follow us
Novartis on Flickr
Stay up-to-date
© 2013 Novartis AG Terms of usePrivacy policy Sitemap